Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Not on Peppol Peppol
Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.
Financials
Financial year 2025
Dr CRUCIL Maxime néphrologie from Seraing, company number BE0800349176, closed financial year 2025 with a result of € 38,443 after tax. For that financial year Dr CRUCIL Maxime néphrologie recorded a gross margin of € 61,088 and equity of € 48,122. Compared with financial year 2024, the result moved from € 5,630 to € 38,443. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on January 23, 2026.
€ 48,122
▲ € 38,443 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 38,443
▲ € 32,813 vs 2024
Profit after tax over the fiscal year.
€ 59,551
▲ 277% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 46,622.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 8,440
▼ 55% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 11,852
▲ 247% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|
| Gross margin | € 8,326 | € 19,520 | € 61,088 | ▲ 213% |
| Profit after taxes | € 2,548 | € 5,630 | € 38,443 | ▲ € 32,813 |
| Equity | € 4,048 | € 9,679 | € 48,122 | ▲ € 38,443 |
| Total debts | € 29,243 | € 24,955 | € 28,069 | ▲ 12% |
| Cash | € 5,852 | € 15,813 | € 59,551 | ▲ 277% |
| Retained profit | € 2,548 | € 8,179 | € 46,622 | ▲ € 38,443 |
| Balance sheet total | € 33,292 | € 34,634 | € 76,191 | ▲ 120% |
Key figures of Dr CRUCIL Maxime néphrologie, fiscal years 2023 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 January 2027.
Ask about Dr CRUCIL Maxime néphrologie the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to Dr CRUCIL Maxime néphrologie?
What happened at Dr CRUCIL Maxime néphrologie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 38,443 (▲ € 32,813 vs 2024). Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Seraing. KBO
In short
From € 2,548 profit in 2023 to € 38,443 profit in 2025.
Paid € 16,375 in corporate taxes since 2023.
Best year ever: 2025, with € 38,443 profit.
Management
Behind Dr CRUCIL Maxime néphrologie is Maxime CRUCIL.
Directors
According to the 2025 annual accounts
Maxime CRUCIL
Director
Establishments
Establishment units
Physical locations of this company
Rue Simone Veil 12
4101 Seraing
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- CRUCIL Maxime Fabio Julien(oprichter) 100%
Details
- Company number
- 0800.349.176
- VAT number
- BE 0800.349.176
- Registered office
- Rue Simone Veil 12, 4101 Seraing
- Names & denominations
- Dr CRUCIL Maxime néphrologie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 4 April 2023
- Peppol
- Not registered